Skip to Content

Join the 'Breast Cancer, Metastatic' group to help and get support from people like you.

Breast Cancer, Metastatic News

Related terms: Metastatic Breast Cancer

Yoga, Meditation May Ease Some Breast Cancer Symptoms

Posted 5 days ago by Drugs.com

FRIDAY, May 19, 2017 – The diagnosis and treatment of breast cancer can come with a lot of anxiety, depression and other symptoms that affect quality of life. But mind-body therapies, such as yoga or meditation, may help ease these troubling concerns, a new study suggests. The researchers reviewed previous studies done on 80 integrative therapies. "We have good evidence that [some] mind-body therapies – such as meditation, yoga, relaxation – can provide benefit to breast cancer patients during and after treatment," said study researcher Heather Greenlee. She's an assistant professor of epidemiology at Columbia University's Mailman School of Public Health. "And we do have evidence that acupuncture is very useful in managing pain," she added. Evidence about dietary supplements and botanicals, however, are lacking when it comes to helping symptoms and side effects, she said. Greenlee ... Read more

Related support groups: Depression, Cancer, Major Depressive Disorder, Breast Cancer, Dysthymia, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer

More U.S. Women Living Longer With Advanced Breast Cancer

Posted 5 days ago by Drugs.com

THURSDAY, May 18, 2017 – The number of U.S. women living with the most advanced stage of breast cancer has been rising since the 1990s, a new study finds. Researchers say that treatment advances, allowing more breast cancer patients to survive longer, are one likely reason. The general aging of the U.S. population is another. Right now, the study estimated, close to 155,000 U.S. women are living with metastatic breast cancer – cancer that has spread beyond the breast to distant sites in the body. That is up from roughly 105,000 in 1990. Breast cancer experts said the figures are actually the first estimates of how many U.S. women are living with metastatic disease. A number has been hard to come by, they said, because there is no national system that tracks cancer recurrences: Since U.S. women are typically diagnosed with earlier-stage breast cancer, most metastatic cases would – ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Osteolytic Bone Metastases of Breast Cancer, Body Imaging

More Cancers Caught Early Since Obamacare

Posted 6 days ago by Drugs.com

THURSDAY, May 18, 2017 – More cancers have been spotted in their early stages since the Affordable Care Act (ACA) became the law of the land, new research finds. Finding breast, colon, cervical and lung cancers early greatly improves the odds of successful treatment, said study author Xuesong Han. She's the strategic director of health policy and health care delivery research at the American Cancer Society. "We wanted to see if the introduction of the ACA affected the diagnosis of these cancers," she said. Although the increase in early-stage cancer diagnosis was only 1 percent, it's a significant increase that includes thousands of patients whose cancer might not have been found until it was too late for effective treatment and potential cure, Han noted. The increases in diagnosis of lung and cervical cancer were mostly among people on Medicaid, she said. A large part of the ACA is ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Cervical Cancer, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Osteolytic Bone Metastases of Breast Cancer

Could Tai Chi Ease Insomnia in Breast Cancer Survivors?

Posted 12 days ago by Drugs.com

FRIDAY, May 12, 2017 – For breast cancer survivors who struggle with sleep, a new study suggests that tai chi might calm their restless nights. Researchers found this slow-moving form of meditation was as good as talk therapy and more effective than medication in treating insomnia and reducing the risk for sleep loss-related health issues, including depression, fatigue and a weakened immune system. "Breast cancer survivors often don't just come to physicians with insomnia. They have insomnia, fatigue and depression," said study leader Dr. Michael Irwin. He directs UCLA's Cousins Center for Psychoneuroimmunology at the Semel Institute for Neuroscience and Human Behavior, in Los Angeles. "And this intervention, tai chi, impacted all those outcomes in a similar way, with benefits that were as robust as the gold standard treatment for insomnia [talk therapy]," Irwin added in a UCLA news ... Read more

Related support groups: Sleep Disorders, Insomnia, Fatigue, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Drowsiness, Breast Cancer, Prevention, Hypersomnia, Breast Cancer - Palliative

Hope for 1st Drug Against Lymphedema, a Cancer Complication

Posted 13 days ago by Drugs.com

WEDNESDAY, May 10, 2017 – Many cancer patients, especially those who've undergone breast cancer treatment, experience painful, swollen limbs, a condition called lymphedema. Now researchers say they've found an underlying mechanism that could eventually lead to the first drug therapy for the debilitating condition. The findings come from research in mice and human cells. However, there's already a clinical trial underway to see whether these lab discoveries will translate into a new lymphedema treatment. It's estimated that 10 million Americans have lymphedema, said Dr. Stanley Rockson, one of the senior researchers on the study. "Even though many people might not recognize the term, it's a very common condition," said Rockson, a professor at Stanford University School of Medicine in Stanford, Calif. People with lymphedema have excess fluid buildup in parts of the body, usually the arms ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Ketoprofen, Breast Cancer, Prevention, Breast Cancer - Palliative, Orudis, Ketoprofen/lidocaine, Actron, LidoProfen, Oruvail, Ketamine/ketoprofen/lidocaine, Orudis KT, Nexcede, Vopac

More Asian-American Women Getting Breast Cancer

Posted 15 Apr 2017 by Drugs.com

FRIDAY, April 14, 2017 – Breast cancer rates among Asian-Americans are steadily rising in contrast to other racial/ethnic groups, a new study suggests. Researchers from the Cancer Prevention Institute of California reviewed data from 1988 to 2013 on breast cancer among women in California from seven Asian ethnic groups. These included Chinese, Japanese, Koreans, Filipinos, Vietnamese, South Asians (Asian Indians and Pakistanis), and Southeast Asians (Cambodians, Laotians, Hmong, Thai). During the study period, all of these groups – except Japanese women – had an overall increase in breast cancer incidence. The largest increases were among Koreans, South Asians and Southeast Asians, the study authors said. "These patterns warrant additional attention to public health prioritization to target disparities in access to care, as well as further research in identifying relevant breast ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention

Mammogram Guidelines Have Changed, But Are Doctors Listening?

Posted 10 Apr 2017 by Drugs.com

MONDAY, April 10, 2017 – Four of five doctors still recommend annual mammograms for women in their early 40s, despite guideline changes that have pushed back the age for yearly breast cancer screening, a new survey shows. Overall, 81 percent of physicians surveyed said they suggest annual mammograms for women aged 40 to 44, while more than two-thirds recommend regular mammograms for women aged 75 or older. "Gynecologists were, in general, more likely to recommend routine mammograms," added lead researcher Dr. Archana Radhakrishnan, an internist with Johns Hopkins University in Baltimore. These practices run counter to guidelines issued by the American Cancer Society, which recommends annual screening starting at 45 and screening every other year from age 55 onward, researchers said in background notes. The doctors also are ignoring the advice of the U.S. Preventive Services Task Force ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Body Imaging

Ibrance (palbociclib) Receives FDA Regular Approval and Expanded Indication for First-Line HR+, HER2- Metastatic Breast Cancer

Posted 3 Apr 2017 by Drugs.com

March 31, 2017 – Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for its first-in-class cyclin dependent kinase 4/6 (CDK 4/6) inhibitor, Ibrance (palbociclib), based on the results from the confirmatory Phase 3 trial PALOMA-2. The FDA action converts the accelerated approval of Ibrance to regular approval and broadens the range of anti-hormonal therapy that may be administered with Ibrance. Ibrance now is indicated in combination with an aromatase inhibitor, expanding on its earlier indication in combination with letrozole, as initial endocrine based therapy in postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. Ibrance is the first CDK 4/6 inhibitor approved by the FDA. Ibrance was ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Ibrance, Palbociclib

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Osteosarcoma, Endometrial Cancer, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Bladder Cancer, Cervical Cancer, Melanoma - Metastatic

Preventive Mastectomy Rates Vary by State

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – In certain areas of the United States, more women diagnosed with early stage breast cancer are choosing to have the unaffected breast removed, new research finds. The study also found that younger women are especially likely to have the second breast removed. Nearly half of women under age 45 diagnosed with early breast cancer in five states opted for the procedure, said the study's senior author, Dr. Ahmedin Jemal. He's vice president of the American Cancer Society's Surveillance and Health Services Research Program. The five states are Colorado, Iowa, Missouri, Nebraska and South Dakota. The study included records from 1.2 million women from 45 states and Washington, D.C. All patients were 20 and older. All had been diagnosed with early stage breast cancer in one breast and were treated with surgery between 2004 and 2012. Between those years, the ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Vascular Surgery

Smokers May Be Prone to Risks From Breast Cancer Radiation Therapy

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – Breast cancer patients who smoke have an increased risk for serious long-term complications from radiation therapy, a new study finds. "This research highlights that breast cancer patients who smoke need to be offered help and support in order to try and quit to minimize any risks from their treatment," Dr. Julie Sharp said in a Cancer Research UK news release. She's head of health information for the research and awareness charity based in the United Kingdom. "It's important to remember that modern-day radiotherapy techniques have been refined and improved to make sure it is targeted and effective while reducing the risk of side effects," Sharp added. British researchers looked at data from nearly 41,000 breast cancer patients. The information came from 75 different studies on radiation therapy for breast cancer. The researchers found that the long-term ... Read more

Related support groups: Smoking, Breast Cancer, Smoking Cessation, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer - Palliative, History - Radiation Therapy

Many Women Who Get Breast Cancer Gene Test Don't Need It

Posted 28 Mar 2017 by Drugs.com

TUESDAY, March 28, 2017 – An increasing number of American women who don't have breast or ovarian cancer are being tested for BRCA and BRCA2 gene mutations associated with those diseases, a new study shows. Mutations in the BRCA1 and BRCA2 genes significantly increase a woman's risk of breast cancer. These mutations are linked to 5 percent to 10 percent of all breast cancer and about 15 percent of ovarian cancers, the U.S. National Cancer Institute says. The new study found that more than 60 percent of BRCA tests are done on women without breast or ovarian cancer. In 2004, that number was just 24 percent. This increase is likely due to increased marketing of BRCA testing. This may lead women at low risk for BRCA mutations to self-refer for testing, the researchers said. While the number of low-risk women being tested has increased, BRCA testing is being underused by at-risk women, the ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Ovarian Cancer, Breast Cancer, Prevention, Diagnosis and Investigation

FDA Approves Kisqali (ribociclib) for HR+/HER2- Metastatic Breast Cancer

Posted 13 Mar 2017 by Drugs.com

Basel, March 13, 2017 - The US Food and Drug Administration (FDA) has approved Kisqali (ribociclib, formerly known as LEE011) in combination with an aromatase inhibitor as initial endocrine-based therapy for treatment of postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer. Kisqali is a CDK4/6 inhibitor approved based on a first-line Phase III trial that met its primary endpoint early, demonstrating statistically significant improvement in progression-free survival (PFS) compared to letrozole alone at the first pre-planned interim analysis[1]. Kisqali was reviewed and approved under the FDA Breakthrough Therapy designation and Priority Review programs. "Kisqali is emblematic of the innovation that Novartis continues to bring forward for people with HR+/HER2- metastatic breast cancer," ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Kisqali, Ribociclib

Soy Safe, Even Protective, for Breast Cancer Survivors

Posted 7 Mar 2017 by Drugs.com

TUESDAY, March 7, 2017 – The pros and cons of soy for breast cancer patients have been debated for years. Now, research involving more than 6,200 breast cancer survivors finds that those who ate the most soy had a lower risk of death from all causes during the nearly 10-year follow-up period. "We didn't find any harmful effects of women diagnosed with breast cancer consuming soy in terms of mortality," said study leader Dr. Fang Fang Zhang. She's an assistant professor of epidemiology at Tufts University's Friedman School of Nutrition Science and Policy in Boston. "Overall, consuming higher levels of soy is associated with a 21 percent reduction in the risk of death compared to women who consumed soy at a lower level," she said. Concerns around soy's "risk/benefit" profile have arisen because the food has estrogen-like compounds called isoflavones. That's important, experts says, ... Read more

Related support groups: Hot Flashes, Breast Cancer, Menopausal Disorders, Postmenopausal Symptoms, Breast Cancer, Metastatic, Soy, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Bad Diet in Youth Might Raise Risk of Early Breast Cancer

Posted 2 Mar 2017 by Drugs.com

THURSDAY, March 2, 2017 – A poor diet while young may do more than just make it tough to fit into a pair of jeans: New research suggests it might also raise a younger woman's risk for breast cancer. "A diet high in sugar, refined carbohydrates, and red and processed meat makes it more likely that you may experience early onset breast cancer," said study senior author Karin Michels. She is chair of epidemiology at the UCLA Fielding School of Public Health, in Los Angeles. An unhealthy diet appeared to increase that risk by more than one-third, but the findings can't prove cause-and-effect, Michels said. "We are talking about a link or association," she noted. The study tracked data from more than 45,000 women enrolled in the Nurses' Health Study II. All of the women completed food frequency questionnaires about their teen and early adult diets, and were followed up for 22 years. The ... Read more

Related support groups: Obesity, Breast Cancer, Menopausal Disorders, Postmenopausal Symptoms, Breast Cancer, Metastatic, Perimenopausal Symptoms, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation

Page 1 2 3 4 5 6 7 8 9 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

tamoxifen, Arimidex, Femara, anastrozole, letrozole, Xeloda, Herceptin, Taxol, Taxotere, view more... Faslodex, capecitabine, paclitaxel, Ibrance, Gemzar, gemcitabine, docetaxel, eribulin, Tykerb, Abraxane, bevacizumab, fulvestrant, Perjeta, Fareston, Kadcyla, Ixempra, Tamoxifen Hexal, trastuzumab, lapatinib, pertuzumab, Tamosin, Tamoxen, Genox, Kisqali, Docefrez, Halaven, Soltamox, ixabepilone, toremifene, ribociclib, palbociclib, ado-trastuzumab emtansine, paclitaxel protein-bound, Onxol, Tamofen, Emblon, Tamone, Nolvadex, Nolvadex D